ASCENDIS HEALTH LIMITED - Dealings in securities by directors

Dealings in securities by directors

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)

Dealings in securities by directors

In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by directors, is disclosed:
Directors:                            Gary Shayne and Crispian Dillon.

Nature of the transactions:           Coast2Coast Capital Proprietary Limited (“C2C”) (in
                                      which Gary Shayne holds an 85% indirect interest and
                                      Crispian Dillon holds a 15% indirect interest), is
                                      required to redeem two existing debentures, entered
                                      into on 26 February 2016 and 19 August 2016
                                      respectively, and each issued by an indirect
                                      subsidiary of C2C, by way of a settlement of Ascendis
                                      shares. The Ascendis shares are thus transferred to
                                      effect the redemption of the debentures, at a price per
                                      share determined using the pre-agreed pricing
                                      mechanism for each debenture.

                                      Furthermore, C2C will indirectly purchase shares in
                                      terms of a put and call option agreement entered into
                                      on 21 May 2015. C2C will purchase the Ascendis
                                      shares at the price determined per the option
                                      agreement.
Date of transaction:                  29 September 2017

Class of shares:                      Ordinary shares

Number of shares                      689,783
Price per share                       R27.53
Value                                 R18,989,725.99
Nature of transactions:               Sale, off market

Number of shares                      5,236,701
Price per share                       R23.43
Value                                 R122,695,904.43
Nature of transactions:               Sale, off market

Number of shares                      266,667
Price per share                       R21.00
Value                                 R5,600,007.00
Nature of transactions:               Purchase, off market

Extent of interest:                   Indirect beneficial (through C2C, in which Gary
                                      Shayne has a 85% indirect beneficial interest and
                                      Crispian Dillon has a 15% indirect beneficial interest).
Written clearance obtained:           Clearance was obtained from the Chairman.

29 September 2017
Johannesburg

Sponsor
Investec Bank Limited

Date: 29/09/2017 10:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.